ISRCTN12595633暂停2 期
A Phase II study on the effect of Brahmi (Bacopa monnieri Linn) in various types and grades of dementia by comparing the effect of the drug on the participants using the Global Deterioration Scale (GDS) and Standardized Mini-Mental State Examination (SMMSE)
Ambalike Clinic0 个研究点目标入组 60 人开始时间: 2019年7月22日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 暂停
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged 18 years and over
- •2. Diagnosis of dementia
排除标准
- •1. History of intolerance or allergy to Brahmi
- •2. Type 1 diabetes mellitus
- •3. Pregnancy
研究者
相似试验
已完成
不适用
Brahmi (Bacopa Monnieri Linn) in the treatment of dementiaDementiaISRCTN18407424Ambalike Clinic12
尚未招募
4 期
Effectiveness of Brahmi versus Walnut on Improvement of Cognitive Performance among Geriatric PopulatioCTRI/2024/03/064714Rama Rani
尚未招募
不适用
Effect of Bhramari Pranayama and Trataka Karma on Sleep DisordersCTRI/2022/11/047642PGIASR DSRRAU JODHPUR RAJASTHA
尚未招募
1 期
Ayurvedic Drug For AnaemiaCTRI/2024/04/065754Dr BRKR Government Ayurvedic Medical College Erragadda Hyderabad
进行中（未招募）
2 期
To compare the efficacy of Brahmi and Haritaki extracts in adolescents with Academic stressCTRI/2022/03/041413MAHATMA GANDHI AYURVED COLLEGE HOSPITAL RESEARCH CENTRE SALODH WARDHA MAHARASHTRA